← SynDRA
GAVESTINEL
SynDRA canonical compound SYN0002324 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
GLRB | GRIN1 | GRIN2A | GRIN2B | GRIN2C | GRIN2D | GRIN3A | GRIN3B
Mechanism of action
glutamate receptor antagonist
All known targets
GLRA1; GLRA2; GLRA3; GLRA4; GLRB
GLRB
GRIN1
GRIN2A
GRIN2B
GRIN2C
GRIN2D
GRIN3A
GRIN3B
Mechanisms of action (all sources)
glutamate receptor antagonist
Modulator
Cross-references
PubChem CID:
6450546
ChEMBL:
CHEMBL44793
DrugBank:
DB06741
ChEBI:
92867
KEGG:
D04308
Wikipedia:
Gavestinel
TTD: D0O6AQ
Synonyms
GV-150526X
GV-150,526A
GV-150526
GV150526
UNII-318X4QY113
318X4QY113
1H-Indole-2-carboxylic acid, 4,6-dichloro-3-(3-oxo-3-(phenylamino)-1-propenyl)-, (E)-
4,6-Dichloro-3-((E)-2-(phenylcarbamoyl)vinyl)indole-2-carboxylic acid
1H-Indole-2-carboxylic acid, 4,6-dichloro-3-((1E)-3-oxo-3-(phenylamino)-1-propenyl)-
(E)-4,6-Dichloro-3-(3-oxo-3-(phenylamino)-1-propenyl)-1H-indole-2-carboxylic acid
GV 150526
Gavestinel (USAN/INN)
AC1O51WR
Gavestinel [USAN:INN:BAN]
CHEMBL44793
SCHEMBL678632
SCHEMBL1721070
gavestinelum
RefChem:639773
DTXCID40200805
GAVESTINEL [INN]
GAVESTINEL [USAN]
GAVESTINEL [MART.]
SCHEMBL30184856
CHEBI:92867
WZBNEZWCNKUOSM-VOTSOKGWSA-N
BDBM50010475
DA-63712
MS-33148
HY-150138
CS-0612182
NS00069212
D04308
BRD-K49890030-236-01-6
BRD-K81981783-236-01-1
BRD-K81981783-236-02-9
HY-107700
HMS3677I04
CS-0029238
Look up GAVESTINEL in the interactive SynDRA portal →